HOOKIPA Pharma Stock Discussion

$HOOKIPA Pharma (HOOK.US)$ flying

$HOOKIPA Pharma (HOOK.US)$  too much naked shorts to press the price down deep

$HOOKIPA Pharma (HOOK.US)$  back above $2 soon.  🚀 🚀 🚀

$HOOKIPA Pharma (HOOK.US)$
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)
HOOKIPA Pharma has announced its decision not to proceed with the previously discussed all-share acquisition of Poolbeg Pharma plc. This decision follows the non-binding discussions announced on January 2, 2025, and a subsequent PUSU extension on January 30, 2025.
The company reserves the right to revisit this decision under specific circumstances, including:...

$HOOKIPA Pharma (HOOK.US)$
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
3 minutes ago, 4:00 AM PST
Via GlobeNewswire
HOOK
Share
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative regimen for human immunodeficiency virus (HIV)
Under the collaboration agreement, HOOKIPA is responsible for advancing the HIV program throug...

$HOOKIPA Pharma (HOOK.US)$
Poolbeg Pharma and HOOKIPA Pharma have provided an update on their potential combination, following announcements from January 2 and 7, 2025. The key update concerns Gilead Sciences' participation in the proposed concurrent Fundraise. Gilead has expressed its intention to:
1. Vote in alignment with HOOKIPA Board's recommendation if a formal offer is m...

$HOOKIPA Pharma (HOOK.US)$
Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA
Poolbeg Pharma and HOOKIPA Pharmahave provided an update on their potential combination, following announcements from January 2 and 7, 2025. The key update concerns Gilead Sciences' participation in the proposed concurrent Fundraise. Gilead has expressed its intention to:
1. Vote in alignment with HOOKIPA Board's recommendation if a formal offer ...

$HOOKIPA Pharma (HOOK.US)$ to weak..?

$HOOKIPA Pharma (HOOK.US)$  no pre market?